Research article | Open | Open Peer Review | Published:
Multimorbidity - not just an older person's issue. Results from an Australian biomedical study
BMC Public Healthvolume 10, Article number: 718 (2010)
Multimorbidity, the simultaneous occurrence of two or more chronic conditions, is usually associated with older persons. This research assessed multimorbidity across a range of ages so that planners are informed and appropriate prevention programs, management strategies and health service/health care planning can be implemented.
Multimorbidity was assessed across three age groups from data collected in a major biomedical cohort study (North West Adelaide Health Study). Using randomly selected adults, diabetes, asthma, and chronic obstructive pulmonary disease were determined clinically and cardio-vascular disease, osteoporosis, arthritis and mental health by self-report (ever been told by a doctor). A range of demographic, social, risk and protective factors including high blood pressure and high cholesterol (assessed bio-medically), health service use, quality of life and medication use (linked to government records) were included in the multivariate modelling.
Overall 4.4% of the 20-39 year age group, 15.0% of the 40-59 age group and 39.2% of those aged 60 years of age or older had multimorbidity (17.1% of the total). Of those with multimorbidity, 42.1% were aged less than 60 years of age. A variety of variables were included in the final logistic regression models for the three age groups including family structure, marital status, education attainment, country of birth, smoking status, obesity measurements, medication use, health service utilisation and overall health status.
Multimorbidity is not just associated with older persons and flexible care management support systems, appropriate guidelines and care-coordination programs are required across a broader age range. Issues such as health literacy and polypharamacy are also important considerations. Future research is required into assessing multimorbidity across the life course, prevention of complications and assessment of appropriate self-care strategies.
Persons with multimorbidity, the simultaneous occurrence of two or more chronic conditions [1, 2] are at increased risk of less than best practice care [3, 4]. They tend to have more frequent and longer hospitalisations [1, 5], greater use of polypharmacy (causing adverse drug effects) [3, 6], spend more on their health [4, 7, 8] and use a greater range of other health care services [3, 4]. As the number of health professionals involved in the patients' care increases, patients are more likely to be faced with conflicting instructions and care pathways, and fragmented medical care, making it more challenging for them to adhere to and piece together these instructions, in turn preventing them from participating effectively in their own care [3, 4, 7, 9, 10]. The breadth of conflicting advice ranges from treatment, management and medication and includes exercise and diet . Compounding these issues is the problem associated with seeking meaningful information focusing on the actual combination of chronic conditions experienced by the individual.
Prevalence estimates for multimorbidity range from 35% to 80% [2, 10–15]. These prevalence estimates vary depending on the method of data collection , definition of chronic conditions , definition of multimorbidity [12, 14, 16–18] and the number of chronic conditions included in the analysis [2, 15, 16]. Many studies have been limited in focus to older persons or have produced results that indicate that multimorbidity is an older persons issue [1, 4, 11–14], although the broadening of the age ranges is called for . Notwithstanding, due to the ageing population and increased longevity, the prevalence of multimorbidity is expected to increase. It is imperative in the current climate of limited health resources, to move beyond focusing on single chronic conditions and older persons only, to a focus on multimorbidity across all age groups [1, 16]. There are important implications for public health and health services/health care planning, especially in regard to the call for increased emphasis on primary care and self management.
Research conducted on these issues in Australia are limited [15, 19], yet there is an increasing need to understand the patterns of care and complexity associated with multiple chronic conditions, and to understand the disease combinations/clusters. Of major concern is the increased costs for both the individual and the health care system and how these costs can be contained [7, 8]. This study used cross-sectional data from an existing Australian cohort study to examine characteristics of those with multiple chronic conditions, and identify patterns including those associated with health service usage and costs among those with multiple chronic conditions, with a focus on the broad age range of participants. We hypothesise that multimorbidity is important across all age-groups with different characteristics within each age group.
Data were obtained from the North West Adelaide Health Study (NWAHS), a population based biomedical cohort study established in 2000 [20, 21]. This study involves people living in the north-west region of Adelaide, South Australia and covers approximately one third of the South Australian population including a broad range of socioeconomic areas. Its purpose is to investigate the prevalence of chronic conditions and associated health related risk factors, and to monitor progression of diseases over time in order to help plan health care provision in South Australia. Stage 1 was conducted between January 2000 and July 2003 with households randomly selected via the electronic white pages. The last person in the household to have had their birthday and be 18 years of age or older was interviewed over the telephone and invited to attend a clinic for baseline clinical assessment. Of the initial sample in stage 1 (n = 10096), 18.6% were ineligible due to non-connected number, non-residential numbers or fax/modem connections. Of the eligible sample (n = 8213), 2.6% (n = 215) could not be contacted and 26.2% (n = 2148) refused an interview. Of those that were interviewed (n = 5850), 4060 attended the clinic, resulting in a participation rate of 69.4%.
Stage 2 was conducted between May 2004 and February 2006. This stage included a Computer Assisted Telephone Interview (CATI), a self completed questionnaire and a biomedical examination at a clinic. Participants completed all or a combination of these assessments, depending on their capabilities and availability. For Stage 2 the eligible cohort of 4060 was reduced to 3957 (due to deaths). A further 5.9% (n = 233) were unable to be contacted and 4.3% (n = 160) provided no further information, resulting in a response rate of 90.1% (n = 3564). Of the participants that were interviewed and/or completed a questionnaire, 81.0% of the eligible sample (n = 3206) attended a clinic appointment. This analysis is limited to Stage 2 of the study. Detailed analysis addressing bias associated with non-representativeness of the study has previously been published .
The chronic conditions used to determine whether a participant had multimorbidity were asthma, cardiovascular disease (CVD), chronic obstructive pulmonary disease (COPD), diabetes, a current mental health condition, arthritis and osteoporosis. A person was deemed to have diabetes if they self-reported having ever been told by a doctor they had the condition or by measurement at the clinic (FPG > = 7.0 mmol/L) . Participants were tested for COPD and asthma at the clinic visit where COPD was determined if FEV1/FVC < 70% and asthma if FEV1 > = 12% & > 200 ml or absolute change greater or equal to 400 ml from pre salbutamol to post salbutamol [24, 25]. Participants self-reported if they had ever been told by a doctor they had arthritis, CVD (heart attack, stroke, angina), osteoporosis or a mental health condition (anxiety, depression, stress related problem, other mental health problem). Multimorbidity was defined as having two or more of these seven conditions [2, 16].
Demographic data included age, sex, education, annual household income, family structure, marital status, work status and country of birth. Data were collected on self-reported risk factors (smoking status, physical activity level, alcohol risk and depressive symptoms in the last week using CES-D ) and clinically measured risk factors (blood pressure, cholesterol, body mass index, waist circumference, waist/hip ratio) using standardised measurements techniques [27–29]. In addition, self-reported data were collected on health service utilisation and health-related quality of life (SF36). All medications that participants were taking, including complementary and alternative medicines, were recorded at the clinic visit. Medicare Benefits Schedule (MBS) records (which includes all services subsidised by the Australian government under the universal health insurance program) and Pharmaceutical Benefits Scheme (PBS) records (which ensures prescription medicines are available at affordable prices to all Australian residents) were obtained after gaining consent from the participant.
The data were weighted by age group, sex, region and probability of selection in the household, to ensure that the sample was representative of the population in the northern and western regions of Adelaide. Descriptive analyses were conducted with SPSS (Version 15.0, SPSS, Chicago, IL, USA).
Univariate odds ratios (OR) were undertaken by age group using STATA V11.0 to examine the association between participants with multiple chronic conditions and a range of related variables. Variables that were statistically significant at the p = 0.25 univariate level  were entered into multivariate logistic regression analyses for each age group, to examine the variables independently associated with multiple chronic conditions. In the case of the number of medications taken, the separate variables for the number of prescribed and number of complementary medications were used in preference to the overall number of medications variable. Nonsignificant variables (p value greater than or equal to 0.05) were subsequently omitted in the modelling process until a satisfactory model was obtained. The Hosmer and Lemeshow Goodness of Fit test was adopted as an indicator of the fit of the model; a non-significant value indicated that the model was a good fit for the data . No adjustments in the final models were made. Tests for collinearity were undertaken.
Ethics approval was obtained from the Central Northern Adelaide Health Service Ethics of Human Research Committee.
The prevalence of multimorbidity was 17.1% (95% CI 15.8 -18.4). Table 1 highlights the prevalence of multimorbidity by age group with 4.4% (95% CI 3.4-5.7) of 20-39 year olds, 15.0% (95% CI 13.1-17.2) of 40-59 year olds and 39.2% (95% CI 35.942.6) of those aged 60 years or older having two or more chronic conditions. Of the 17.1% with multiple chronic conditions, 69.1% (95% CI 65.1 -72.8) had two chronic conditions, 22.9% (95% CI 19.6 -26.6) had three chronic conditions and 8.0% (95% CI 6.0 -10.6) had four or more chronic conditions. Of those with multimorbidity, 57.9% (95% CI 53.8 -62.0) are in the older age group with 42.1% (95% CI 38.0 46.2) aged less than 60 years of age.
Table 2 details the combination of chronic diseases with 24.5% (95% CI 21.2-28.4) of those with multimorbidity having arthritis and a mental health condition and 22.9% (95% CI 19.6-26.6) having arthritis and asthma. This equates to 4.3% (95% CI 3.65.0) and 4.0% (95% CI 3.3-4.7) of the total sample. When analysed by age group, the main clusters were asthma and a mental health condition for 20-39 year olds (67.1%; 95% CI 53.9 -78.1), arthritis and mental health for 40-59 year olds (38.2%; 95% CI 31.3 -45.6) and arthritis and asthma for 60+ year olds (25.2%; 95% CI 20.7 -30.2). Univariate analysis demonstrated that multimorbidity was statistically significantly higher for a range of demographic (Table 3), risk factor (Table 4) and health related variables (Table 5) for each age group.
Multivariate logistic regression analyses (Table 6 and Table 7) were undertaken for each of the three age groups and revealed that those with multiple chronic conditions aged 20 to 39 years (Goodness of Fit X2 = 4.55, p = 0.81) were statistically significantly more likely to be living with a partner, have a secondary level of education, be born in the United Kingdom or Ireland, have a high waist circumference and have MBS costs of $2000 or more. Those aged 40 to 59 years (Goodness of fit X2 = 5.52, p = 0.70) were statistically significantly more likely to be living with a partner or living alone, be separated, divorced or widowed, be a current smoker, have a high waist hip ratio, have depressive symptoms, be using prescribed medicines, have MBS costs of over $6000 and self report that they have a fair overall health status. People aged over 60 years of age (Goodness of fit X2 = 7.73, p = 0.46) were statistically significantly more likely be living alone or with unrelated adults, have a secondary level of education or trade, certificate or diploma, have used five or more health services in the last year, use prescribed medicines, have over 150 PBS items processed in the previous three years, and have fair or poor overall health status. No collinearity was found in any model.
This analysis has used data from a randomly selected sample of community living Australians to describe, by age group, the demographic, risk factor, health service utilisation and quality of life of people living with more than one chronic condition. The results indicate that the profile of people living with multimorbidity is different for each age group but on the whole these people are more likely to take medications, spend more on their health and have a lower quality of life. There was no difference by gender which was also observed in a previous Australian study .
The overall prevalence of multimorbidity of 17.1% is lower than previous studies due to the population-wide, random nature of the sample and the limited total number of chronic conditions assessed. Previous studies have used a variety of non-random, or non-population wide samples or used specific older populations [2, 4, 11, 12, 14]. Results from our study support the finding that the prevalence of multimorbidity increases with age. Although Smith and Dourd  argue that multimorbidity is a "normal state of affairs" for those aged over 65 years of age, this study has highlighted that multimorbidity is also a problem in younger age groups with over 40% of those having multimorbidity aged less than 60 years of age. Mercer et al  call for more research of multimorbidity across the life course for prevention and early intervention purposes but also because younger people fail to qualify for the typical geriatric care services that seem to be the focus for multiple chronic conditions.
Polypharmacy was an issue for both the 40-59 and 60+ age groups with both groups over ten times more likely to be taking four-or-more prescribed medications on a daily basis, in turn increasing the risk of adverse drug effects and increasing health care costs to the individual [13, 31]. This research has no relevant data on adverse outcomes or mortality often associated with polypharmacy . Medication costs are a cause for concern for health systems as well as for the person with the conditions . In this study all groups were associated with increasing health care costs - MBS for younger people, prescribed medication and MBS for the 40-59 year olds and prescribed medications and PBS items for the older groups.
Of particular significance is the fact that 40-59 year olds with multimorbidity are 1.71 times more likely to be current smokers than non-smokers. One has to ask if these people with multiple chronic conditions are smoking because of their health status or was smoking the cause of their multimorbidity. This needs to be further investigated and appropriate promotion activities targeted. Previous studies have linked smoking and mental health conditions suggesting that cigarette smoking might ease anxiety and depression . However, it must also be highlighted that smokers have a greater risk for depression which increases with the severity of nicotine dependence. Therefore, smoking status and the likelihood of depressive symptoms in those with multimorbidity is strongly inter-related.
Results of the multivariate analyses indicate that participants aged 20-39 years with lower education levels were statistically significantly more likely to have multiple morbidities compared to those with higher education levels. Although previous studies have shown this relationship , it is normally within older age groups whose education opportunities have historically been limited although in this age group it could be that formal education is still being undertaken and, as such, the educational level may be an underestimation.
Obesity, in terms of high waist circumference for 20-39 year olds and waist hip ratio for 40-59 year olds has also previously been shown to be linked with multimorbidity [11, 32] with rates of obesity increasing in line with the number of chronic conditions. The major public health emphasis on healthy weight should have rebound effects on the prevalence of multimorbidity in the future.
One of the major strengths of this study is the use of a large randomly selected sample of the South Australian population. The large sample size allows for greater generalisation of results. Clinically accessed information on chronic conditions also contributes to the strength of this study. Combining this with data collected on a wide range of risk factors and socio-demographic variables allows for a rich data source which can be analysed by various means. Linking participants MBS and PBS data provides a further insight into health care utilisation and cost, highlighting which chronic conditions or combinations of chronic conditions require significant care and in turn how costly this care can be. The weaknesses of this study include the cross-sectional nature of the data collection with the consequent inability to determine direction of effect. In addition, the reliance on self-report for some of the assessed variables is vulnerable to social desirability or other biased responses.
We recognise that there are limitations of this study, particularly the shortcoming associated with self-reported data collection. In addition, sampling by telephone directory is likely to under sample some groups in the community. The study also only involves community living adults and as such people living in supported accommodation such as aged care facilities were, on the whole, not included although 'home' visits to the new place of residence was undertaken if acceptable and appropriate. Detailed analysis of the bias of the NWAHS sample caused both by telephone sampling and self-reported measures has been assessed and published . Another limitation of the study is that not all chronic conditions (i.e. cancer, deafness, sight problems, dementia) were included in the definition of what was reported as a chronic condition. Other studies, especially those using clinical notes or administrative databases, have used the full list of ICD codes and hence our study, limiting itself to seven chronic conditions, will be an underestimation of the true prevalence of multimorbidity in the Australian society. A further weakness of the study was the fact that no indicator of levels of severity such as the Cumulative Illness Rating Scale, CIRS) , the Index of Coexisting Disease, the Kaplan Index, or Charlson Index  were used. All chronic conditions were treated equally when in fact one or more of the chronic conditions could have a more dominant effect. A further adaptation to the study design could be undertaken by incorporating conditions such as hypertension, hypercholesterolemia, and obesity as chronic conditions rather than risk factors, as described by others [14, 15].
Further research is required in this relatively new field, especially in regard to interventions to improve outcomes for people with multimorbidity, to determine the relationship between multimorbidity and shared risk factors , to access the effect of multimorbidity across the life course, to investigate the effect on carers, to prevent complications attributed to multimorbidity  and to investigate the barriers and increased difficulties associated with self-care [16, 34]. Developing appropriate self-management strategies for people with clusters of chronic diseases are important.
Preventing, treating and managing chronic conditions is complex but is one of the major challenges facing the health care systems. This research has identified a range of factors associated with multimorbidity such as family structure, marital status, education level, country of birth, medication use, health service use, existence of depressive symptoms, smoking status, overall health status, high waist hip ratio and waist circumference which vary according to age group. This valuable information and increased understanding can lead to improved prevention strategies. Important in forward endeavours is the need to access and modify the many clinical guidelines and disease management programs that concentrate on single conditions [3, 34]. Flexibility within the shared decisions making strategies is crucial and importance must be placed on the need for effective communication. Multimorbidity often requires flexible care management support systems and care co-ordination programs, and the current challenge is to accommodate these needs in the complex, multidimensional world of multimorbidity.
Computer Assisted Telephone Interviewing
Centre for Epidemiologic Studies Depression Scale
Cumulative Illness Rating Scale
Chronic Obstructive Pulmonary Disease
Cardio Vascular Disease
Forced expiratory volume in one second
Fasting plasma glucose
Forced vital capacity
International Classification of Diseases
Medicare Benefits Schedule
North West Adelaide Health Study
Pharmaceutical Benefits Scheme
Short Form - 36
Statistical Package for Social Sciences
Smith S, O'Dowd T: Chronic diseases: what happens when they come in multiples?. British Journal of General Practice. 2007, 57 (537): 268-270.
Fortin M, Bravo G, Hudon C, Vanasse A, Lapointe L: Prevalence of Multimorbidity among adults seen in Family Practice. Annals of Family Medicine. 2005, 3 (3): 223-228. 10.1370/afm.272.
Vogeli C, Shields AE, Lee TA, Gibson TB, Marder WD, Weiss KB, Blumenthal D: Multiple chronic conditions: prevalence, health consequences, and implications for quality, care management and costs. Journal of General Internal Medicine. 2007, 22 (Suppl 3): 391-395. 10.1007/s11606-007-0322-1.
Bayliss EA, Edwards AE, Steiner JF, Main DS: Processes of care desired by elderly patients with multimorbidities. Family Practice. 2008, 25 (4): 287-93. 10.1093/fampra/cmn040.
Cordelius A, Edberg AK, Jakobsson U, Hallberg IR: Hospital admissions among people 65+ related to multimorbidity, municipal and outpatient care. Archives of Gerontology & Geriatrics. 2008, 46 (1): 41-55.
Wehling M: Multimorbidity and polypharmacy: how to reduce the harmful drug load and yet add needed drugs in the elderly? Proposal of a new drug classification: fit for the aged. Journal of the American Geriatrics Society. 2009, 57: 560-561. 10.1111/j.1532-5415.2009.02131.x.
McCormick WC, Boling PA: Multimorbidity and a comprehensive Medicare care-coordination benefit. Journal of the American Geriatrics Society. 2005, 53: 2227-2228. 10.1111/j.1532-5415.2005.00504.x.
Bodenheimer T, Fernandez A: High and rising health care costs. Part 4: Can costs be controlled while preserving quality?. Annals of Internal Medicine. 2005, 143: 26-31.
Loeb SJ, Penrod J, Falkenstern S, Guelder SH, Poon LW: Supporting older adults living with multiple chronic conditions. Western Journal of Nursing Research. 2003, 25 (1): 8-23. 10.1177/0193945902238830.
Starfield B, Lemke KW, Bernhardt T, Foldes SS, Forrest CB, Weiner JP: Comrobidity: Implications for the importance of Primary Care in 'case' management. Annals of Family Medicine. 2003, 1 (1): 8-14. 10.1370/afm.1.
Nagel G, Peter R, Braig S, Hermann S, Rohrmann S, Linseisen J: The impact of education on risk factors and the occurrence of multimorbidity in the EPIC-Heidelberg cohort. BMC Public Health. 2008, 8 (1): 384-10.1186/1471-2458-8-384.
Schram MT, Frijters D, van de Lisdonk EH, Ploemacher J, de Craen AJM, de Waal MWM, Rooij FJ, Heeringa J, Hofman A, Deeg DJH, Schellevis FG: Setting and registry characteristics affect the prevalence and nature of multimorbidity in the elderly. Journal of Clinical Epidemiology. 2008, 61: 1104-1112. 10.1016/j.jclinepi.2007.11.021.
Marengoni AB, Winblad B, Karp A, Fratiglioni L: Prevalence of chronic diseases and multimorbidity among the elderly population in Sweden. American Journal of Public Health. 2008, 98: 1198-1200. 10.2105/AJPH.2007.121137.
Marengoni A, Rizzuto D, Wang HX, Winblad B, Fratiglioni L: Patterns of chronic multimorbidity in the elderly population. Journal of the American Geriatrics Society. 2009, 57: 225-230. 10.1111/j.1532-5415.2008.02109.x.
Britt HC, Harrison CM, Miller GC, Knox SA: Prevalence and patterns of multimorbidity in Australia. Medical Journal of Australia. 2008, 189 (2): 72-77.
Mercer SW, Smith SM, Wyke S, O'Dowd T, Watt GC: Multimorbidity in primary care: developing the research agenda. Family Practice. 2009, 26 (2): 79-80. 10.1093/fampra/cmp020.
Rozzini R, Sabatini T, Barbisoni P: How to measure comorbidity in elderly person. Journal of Clinical Epidemiology. 2004, 57: 321-322. 10.1016/j.jclinepi.2003.08.001.
de Groot V, Beckerman H, Lankhorst GJ, Bouter LM: Journal of Clinical Epidemiology. 2003, 56 (3): 221-9.
Tooth L, Hockey R, Byles J, Dobson A: Weighted multimorbidity indexes predicted mortality, health service use, and health-related quality of life in older women. Journal of Clinical Epidemiology. 2008, 61 (2): 151-9. 10.1016/j.jclinepi.2007.05.015.
Grant JF, Chittleborough CR, Taylor AW, Dal Grande E, Wilson DH, Phillips PJ, Adams RJ, Cheek J, Price K, Gill T, Ruffin RE, North West Adelaide Health Study Team: The North West Adelaide Health Study: methodology and baseline segmentation of a cohort along a chronic disease continuum. Epidemiologic Perspectives & Innovations. 2006, 3: 4-
Grant JF, Taylor AW, Ruffin RE, Wilson DH, Phillips PJ, Adams RJT, Price K, North West Adelaide Health Study Team: Cohort profile: The North West Adelaide Health Study. International Journal of Epidemiology. 2008, 1-8.
Taylor AW, Dal Grande E, Gill T, Chittleborough CR, Wilson DH, Adams R, Grant JF, Ruffin R, North West Adelaide Health Study team: Do people with risky behaviours participate in biomedical cohort studies. BMC Public Health. 2006, 6: 9-10.1186/1471-2458-6-11.
Chittleborough C, Baldock , Taylor A, Phillips P: Health status assessed by the SF-36 along the diabetes continuum in an Australian population. Quality of Life Research. 2006, 15 (4): 687-94. 10.1007/s11136-005-3570-8.
Wilson D, Adams R, Appleton S, Ruffin R: Difficulties identifying and targeting COPD and population-attributable risk of smoking - a population study. Chest. 2005, 128: 2035-42. 10.1378/chest.128.4.2035.
Appleton S, Adams R, Wilson D, Taylor A, Ruffin R: Spirometric criteria for asthma: adding further evidence to the debate. Journal of Allergy and Clinical Immunology. 2005, 116: 976-82. 10.1016/j.jaci.2005.08.034.
Radloff L: The CES-D scale: A self-report depression scale for research in the general population. Applied Psychocology Measurement. 1977, 1: 385-401. 10.1177/014662167700100306.
Taylor AW, Dal Grande E, Gill TK, Chittleborough CR, Wilson DH, Adams RA, Grant JF, Phillips P, Appleton S, Ruffin RE: How valid are self-reported height and weight? A comparison between CATI self-report and clinic measurements using a large representative cohort study. Australia and New Zealand Journal of Public Health. 2006, 30: 238-46. 10.1111/j.1467-842X.2006.tb00864.x.
Gill T, Chittleborough C, Taylor A, Ruffin R, Wilson D, Phillips P: Body mass index, waist hip ratio, and waist circumference: which measure to classify obesity?. Soz Praventivmed. 2003, 48 (3): 191-200.
Taylor AW, Dal Grande E, Gill T, Pickering S, Grant J, Adams R, Phillips P, on behalf of the NWAHS team: Comparing self-reported and measured high blood pressure and high cholesterol status using data from a large representative cohort study. Australian New Zealand Journal of Public Heath. 2010,
Hosmer D, Lemeshow S: Applied Logistic Regression. 2000, New York John Wiley & Sons, 2
Kaufman DW, Kelly JP, Rosenberg L, Anderson TE, Mitchell AA: Recent patterns of medication use in the ambulatory adult population of the United States. The Slone survey. JAMA. 2002, 287: 337-344. 10.1001/jama.287.3.337.
Keizer I, Gex-Fabry M, Eytan A, Bertschy G: Smoking in psychiatric inpatients: Association with working status, diagnosis, comorbid substance abuse and history of suicide attempts. Addictive Behaviors. 2009, 34 (10): 815-820. 10.1016/j.addbeh.2009.03.018.
Gijsen R, Hoeymands N, Schellevis FG, Ruwaard D, Satariono WA, van den Bos GA: Causes and consequences of co-mordidity: a review. Journal of Clinical Epidemiology. 2001, 54 (7): 661-74. 10.1016/S0895-4356(00)00363-2.
Bayliss EA, Steiner JF, Fernald DH, Crane LA, Main DS: Descriptions of barriers to self-care by persons with comorbid chronic diseases. Annals of Family Medicine. 2003, 1 (1): 15-21. 10.1370/afm.4.
The pre-publication history for this paper can be accessed here:http://www.biomedcentral.com/1471-2458/10/718/prepub
The study team are most grateful for the generosity of the cohort participants in the giving of their time and effort to the study. The study team is also very appreciative of the work of the study management, clinic, recruiting and research support staff for their substantial contribution to the success of the study.
The authors declare that they have no competing interests.
AT conceived the design of the study, participated in the co-ordination of the study and drafted the manuscript. KP participated in the design and co-ordination of the study and was involved in the drafting of the manuscript. TG participated in the design and co-ordination of the study, performed statistical analyses and was involved in the drafting of the manuscript. RA participated in the design and co-ordination of the study, and was involved in the drafting of the manuscript. RP performed statistical analyses and was involved in the drafting of the manuscript. NC performed statistical analyses and was involved in the drafting of the manuscript. ZS performed statistical analyses and was involved in the drafting of the manuscript. DW conceived the design of the study, participated in the co-ordination of the study, and was involved in the drafting of the manuscript. All authors read and approved the final manuscript.
Authors’ original submitted files for images
About this article
- Chronic Obstructive Pulmonary Disease
- Chronic Condition
- Mental Health Condition
- Health Service Utilisation
- Pharmaceutical Benefit Scheme